Ultralife Corporation (NASDAQ:ULBI – Get Free Report) Director Bradford Whitmore purchased 8,700 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was bought at an average cost of $6.33 per share, with a total value of $55,071.00. Following the completion of the acquisition, the director directly owned 1,983,335 shares of the company’s stock, valued at approximately $12,554,510.55. This trade represents a 0.44% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link.
Ultralife Price Performance
Ultralife stock opened at $7.76 on Friday. Ultralife Corporation has a one year low of $4.90 and a one year high of $9.52. The business has a fifty day moving average price of $6.79 and a 200-day moving average price of $6.25. The company has a debt-to-equity ratio of 0.34, a current ratio of 2.56 and a quick ratio of 1.23. The firm has a market capitalization of $129.28 million, a P/E ratio of -15.52 and a beta of 0.74.
Ultralife (NASDAQ:ULBI – Get Free Report) last posted its quarterly earnings results on Friday, May 8th. The technology company reported ($0.03) EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.18). Ultralife had a positive return on equity of 1.15% and a negative net margin of 4.37%.The company had revenue of $47.45 million during the quarter, compared to the consensus estimate of $52.40 million.
Hedge Funds Weigh In On Ultralife
Ultralife Company Profile
Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.
Recommended Stories
- Five stocks we like better than Ultralife
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.
